Stephen Bazzano
Family Medicine · Galena, KSNPI 1063423150
Payments from drug & device makers
Across 158 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$630
- Lilly USA, LLC$362
- Pfizer$350
- Teva Pharmaceuticals USA, Inc.$163
- GSK$130
- AstraZeneca$111
- plus $508 from 13 others
What the payments were for
- Food & beverage$2,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $630 |
| Lilly USA, LLC | 23 | $362 |
| Pfizer | 26 | $350 |
| Teva Pharmaceuticals USA, Inc. | 12 | $163 |
| GSK | 9 | $130 |
| AstraZeneca | 8 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $98 |
| Mylan Specialty L.p. | 5 | $71 |
| Boehringer Ingelheim | 4 | $63 |
| Merck | 3 | $59 |
| Edwards Lifesciences | 2 | $33 |
| Johnson & Johnson | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Eisai Inc. | 2 | $28 |
| Apria Healthcare LLC | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Novartis | 1 | $12 |
How this compares
$2,254 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $20,218 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $851 |
| Gabapentin | 49 | $656 |
| Omeprazole | 43 | $542 |
| Atorvastatin Calcium | 47 | $373 |
| Pantoprazole Sodium | 32 | $317 |
| Sucralfate | 12 | $297 |
| Potassium Chloride | 20 | $286 |
| Rosuvastatin Calcium | 35 | $209 |
| Amlodipine Besylate | 32 | $188 |
| Losartan Potassium | 20 | $185 |
| Lisinopril | 29 | $163 |
| Levothyroxine Sodium | 14 | $150 |
| Tramadol Hcl | 11 | $111 |
| Alendronate Sodium | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $350 | $20,21817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Galena
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.